Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
doi: 10.1007/s004010000287, 35
Melanotan-2 remains the only available pharmacological tool allowing the simultaneous study of the relative contributions of the four MCR receptors using selective antagonism protocols (HS024 for MC4R, JNJ-10229570 for MC3R, etc.)
Coverage depends on your specific plan and eligibility criteria
& Ichinose, H
Funding The author(s) declare that financial support was received for the research, authorship, and/or publication of this article
US$ 25.26
US$ 23.37
US$ 21.68
US$ 23.09
US$ 27.76
US$ 23.07
US$ 22.64
US$ 28.86
US$ 26.19
US$ 24.74
US$ 20.45
